Ascentage Pharma Group International (AAPG) Current Assets: 2023-2025

  • Ascentage Pharma Group International's Current Assets was N/A to $263.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $263.9 million, marking a year-over-year change of. This contributed to the annual value of $202.0 million for FY2024, which is 6.18% up from last year.
  • Ascentage Pharma Group International's Current Assets amounted to $263.9 million in Q2 2025, which was up 30.66% from $202.0 million recorded in Q4 2024.
  • In the past 5 years, Ascentage Pharma Group International's Current Assets ranged from a high of $263.9 million in Q2 2025 and a low of $186.7 million during Q4 2023.
  • For the 3-year period, Ascentage Pharma Group International's Current Assets averaged around $217.5 million, with its median value being $202.0 million (2024).
  • Data for Ascentage Pharma Group International's Current Assets shows a peak YoY increased of 8.18% (in 2024) over the last 5 years.
  • Over the past 3 years, Ascentage Pharma Group International's Current Assets (Quarterly) stood at $186.7 million in 2023, then climbed by 8.18% to $202.0 million in 2024, then reached $263.9 million in 2025.
  • Its Current Assets was $263.9 million in Q2 2025, compared to $202.0 million in Q4 2024 and $186.7 million in Q4 2023.